FDA-Approved
Treatments |
Protease
Inhibitors |
| Agenerase
(amprenavir)
|
| Aptivus
(tipranavir) |
| Crixivan
(indinavir) |
| Invirase
(saquinavir
hard gel) |
| Kaletra
(lopinavir/ritonavir) |
| Lexiva
(fosamprenavir)
|
| Norvir
(ritonavir) |
| Prezista
(darunavir) |
| Reyataz
(atazanavir)
|
 | Viracept
(nelfinavir) |
Nucleoside
/ Nucleotide Reverse Transcriptase Inhibitors |
 | Combivir
(zidovudine/lamivudine) |
 | Epivir
(lamivudine;
3TC) |
 | Emtriva
(emtricitabine;
FTC) |
 | Epzicom
(abacavir
+ lamivudine) |
 | Retrovir
(zidovudine;
AZT) |
 | Trizivir
(abacavir
+ zidovudine +lamivudine) |
 | Truvada (tenofovir
/ emtricitabine) |
 | Videx
(didanosine;
ddI) |
 | Viread
(tenofovir) |
 | Zerit
(stavudine;
d4T) |
 | Ziagen
(abacavir)
|
non
Nucleoside Reverse Transcriptase Inhibitors
|
 | Rescriptor
(delavirdine)
|
 | Sustiva
(efavirenz) |
 | Viramune
(nevirapine) |
Entry
Inhibitors (including Fusion Inhibitors) |
 | Fuzeon
(enfuvirtide,
T-20) |
 | Selzentry
( maraviroc) |
Fixed-dose
Combinations |
 | Atripla
(efavirenz
+ emtricitabine + tenofovir) |
 | Combivir
(zidovudine
+ lamivudine) |
 | Trizivir
(abacavir
+ zidovudine + lamivudine) |
 | Truvada
(tenofovir + emtricitabine) |